Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 28393 [2012-11551]

Download as PDF Federal Register / Vol. 77, No. 93 / Monday, May 14, 2012 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Research to Prevent Prescription Drug Overdoses, FOA CE12–007, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 12:00 p.m.–4:00 p.m., June 14, 2012 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Research to Prevent Prescription Drug Overdoses, FOA CE12–007, initial review.’’ Contact Person for More Information: Jane Suen, Dr.P.H., M.S., Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop F63, Atlanta, Georgia 30341–3724, Telephone (770) 488–4281. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: May 3, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. and Research and Technical Assistance for Public Health Laboratories in Haiti to Support Post Earthquake Reconstruction, Cholera and HIV/AIDS Response, FOA GH12–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 10:00 a.m.–12:00 p.m., June 26, 2012 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Research and Technical Assistance for Public Health Interventions in Haiti to Support Post Earthquake Reconstruction, Cholera and HIV/AIDS Response, FOA GH12–001,’’ and ‘‘Research and Technical Assistance for Public Health Laboratories in Haiti to Support Post Earthquake Reconstruction, Cholera and HIV/ AIDS Response, FOA GH12–002, initial review.’’ Contact Person for More Information: Hylan D. Shoob, Ph.D., M.S.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, Georgia 30333, Telephone: (404) 639–4796. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: May 4, 2012. Cathy Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–11550 Filed 5–11–12; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2012–11551 Filed 5–11–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families emcdonald on DSK29S0YB1PROD with NOTICES Centers for Disease Control and Prevention Proposed Information Collection Activity; Comment Request Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Research and Technical Assistance for Public Health Interventions in Haiti to Support Post Earthquake Reconstruction, Cholera and HIV/AIDS Response, FOA GH12–001, VerDate Mar<15>2010 14:46 May 11, 2012 Jkt 226001 Proposed Projects Title: Cross-Site Evaluation of the Infant Adoption Awareness Training Program for Projects Initially Funded in Fiscal Year 2006. OMB No.: 0970–0371. Background and Brief Description: The Administration for Children and PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 28393 Families’ (ACF) Children’s Bureau (CB), is requesting extension of the OMBapproved data collection instruments used in the Cross-Site Evaluation of the Infant Adoption Awareness Training Program (IAATP). The instruments that require extension include the IAATP Trainee Pretest Survey and the IAATP Trainee Follow-up Survey. Title XII, Subtitle A, of the Children’s Health Act of 2000 (CHA) authorizes the Department of Health and Human Services to make Infant Adoption Awareness Training grants available to national, regional, and local adoption organizations for the purposes of developing and implementing programs that train the staff of public and nonprofit private health service organizations to provide adoption information and referrals to pregnant women on an equal basis with all other courses of action included in nondirective counseling of pregnant women. Section 1201(a)(2)(A) of the IAATP legislation requires grantees to develop and deliver trainings that are consistent with the Best Practice Guidelines for Infant Adoption Awareness Training. The IAATP guidelines address training goals, basic skills, curriculum and training structure. A complete description of the guidelines is available at https:// www.acf.hhs.gov/programs/cb/ programs_fund/discretionary/iaatp.htm. The funded adoption organizations agree to make every effort to ensure that the recipients of the training are the staff of ‘‘eligible health centers’’ as specified in the grant. As defined in the legislation, these entities include: (a) Eligible health centers that receive grants under authority contained in Title X of the Public Health Service Act (relating to voluntary family planning projects); (b) eligible health centers that receive grants under Section 330 of the Public Health Service Act (relating to community health centers, migrant health centers, and centers regarding homeless individuals and residents of public housing); and (c) eligible health centers that receive grants under the Children’s Health Act of 2000 for the provision of services in schools (subsection (a)(5), 42 U.S.C. 254c– 6(a)(5)(C)). A total of six organizations were awarded IAATP funding in FY2006. In 2011, each of these organizations was awarded a new grant for a brief (17 month) project period. The purpose of the new project period, which commenced October 1, 2011, is for the grantees to enhance, adopt, or adapt their existing IAATP curriculum; implement the modified training; and evaluate the outcomes of participants in E:\FR\FM\14MYN1.SGM 14MYN1

Agencies

[Federal Register Volume 77, Number 93 (Monday, May 14, 2012)]
[Notices]
[Page 28393]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-11551]



[[Page 28393]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Research to Prevent 
Prescription Drug Overdoses, FOA CE12-007, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 12:00 p.m.-4:00 p.m., June 14, 2012 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Research to Prevent Prescription Drug Overdoses, FOA 
CE12-007, initial review.''
    Contact Person for More Information: Jane Suen, Dr.P.H., M.S., 
Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop 
F63, Atlanta, Georgia 30341-3724, Telephone (770) 488-4281.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: May 3, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-11551 Filed 5-11-12; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.